Clozapine toxicity: A discussion of pharmacokinetic factors

Bertilsson, 1994, Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test, Am. J. Psychiatry, 38, 471 Carrillo, 1998, Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients, J. Clin. Psychopharmacol., 18, 311, 10.1097/00004714-199808000-00011 CLOZARIL (Clozapine) Novartis, 2001a. Physicians’ Desk Reference. 55, pp. 2042–2044. CLOZARIL (Clozapine) Novartis, 2001b. AHFS Drug Information, 27, pp. 1739–1742. Dequardo, 1996, Elevated clozapine levels after fluvoxamine initiation (Letter), Am. J. Psychiatry, 153, 840, 10.1176/ajp.153.6.840b Hiemke, 1994, Elevated levels of clozapine in serum after addition of fluvoxamine, J. Clin. Psychopharmacol., 14, 279, 10.1097/00004714-199408000-00011 Johnson, 2000, CYP1A2 and CYP2D6 4-hydroxylates propranolol and both reactions exhibit racial differences, J. Pharmacol. Exp. Ther., 294, 1099 Khan, 2005, Examining concentration-dependent toxicity of clozapine: role of therapeutic drug monitoring, J. Psychiatr. Pract., 11, 289, 10.1097/00131746-200509000-00003 Naranjo, 1981, A method for estimating the probability of adverse drug reactions, Clin. Pharmacol. Ther., 30, 239, 10.1038/clpt.1981.154 Perry, 1991, Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients, Am. J. Psychiatry, 148, 231 Pirmohamed, 1995, Metabolism and bioactivation of Clozapine by human liver in vitro, J. Pharmacol. Exp. Ther., 272, 984 Weigmann, 1993, Interactions of fluvoxamine with the metabolism of clozapine (Letter), Am. J. Psychiatry, 26, 209